CYCN Latest Press Releases, Cyclerion Therapeutics Inc Corporate News

Releases

1.340

-1.47%

-0.020

All
Financials
Insiders

4 | Cyclerion Therapeutics, Inc.(0001755237)
08/07/2024 12:06
8-K | Cyclerion Therapeutics, Inc.(0001755237)
08/07/2024 03:15
10-Q | Cyclerion Therapeutics, Inc.(0001755237)
08/07/2024 02:47
SC 13G/A | Cyclerion Therapeutics, Inc.(0001755237)
07/12/2024 14:18
8-K | Cyclerion Therapeutics, Inc.(0001755237)
06/14/2024 12:07
10-Q | Cyclerion Therapeutics, Inc.(0001755237)
05/07/2024 12:32
DEFA14A | Cyclerion Therapeutics, Inc.(0001755237)
04/29/2024 12:22
DEF 14A | Cyclerion Therapeutics, Inc.(0001755237)
04/29/2024 12:19
8-K | Cyclerion Therapeutics, Inc.(0001755237)
04/18/2024 12:07
3 | Cyclerion Therapeutics, Inc.(0001755237)
03/11/2024 12:06
10-K | Cyclerion Therapeutics, Inc.(0001755237)
03/05/2024 11:18
SC 13G/A | Cyclerion Therapeutics, Inc.(0001755237)
02/14/2024 11:10
SC 13G/A | Cyclerion Therapeutics, Inc.(0001755237)
02/09/2024 12:08
SC 13G/A | Cyclerion Therapeutics, Inc.(0001755237)
02/09/2024 03:52
CORRESP | Cyclerion Therapeutics, Inc.(0001755237)
01/30/2024 04:48
UPLOAD | Cyclerion Therapeutics, Inc.(0001755237)
01/30/2024 04:48
UPLOAD | Cyclerion Therapeutics, Inc.(0001755237)
01/30/2024 04:48
4 | Cyclerion Therapeutics, Inc.(0001755237)
01/26/2024 11:09
4 | Cyclerion Therapeutics, Inc.(0001755237)
01/26/2024 11:06
SC 13G/A | Cyclerion Therapeutics, Inc.(0001755237)
01/22/2024 10:45
3 | Cyclerion Therapeutics, Inc.(0001755237)
12/11/2023 12:10
3 | Cyclerion Therapeutics, Inc.(0001755237)
12/07/2023 11:06
3/A | Cyclerion Therapeutics, Inc.(0001755237)
12/07/2023 11:06
SC 13D/A | Cyclerion Therapeutics, Inc.(0001755237)
12/05/2023 11:01
8-K | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 12:10
3 | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 11:06
4 | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 11:06
4 | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 11:06
4 | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 11:06
4 | Cyclerion Therapeutics, Inc.(0001755237)
12/04/2023 11:05
8-K | Cyclerion Therapeutics, Inc.(0001755237)
12/01/2023 03:02
8-K | Cyclerion Therapeutics, Inc.(0001755237)
11/24/2023 08:07
10-Q | Cyclerion Therapeutics, Inc.(0001755237)
11/13/2023 12:08
8-K | Cyclerion Therapeutics, Inc.(0001755237)
10/23/2023 12:59
SC 13G | Cyclerion Therapeutics, Inc.(0001755237)
09/05/2023 12:06
4 | Cyclerion Therapeutics, Inc.(0001755237)
08/11/2023 12:26
S-8 | Cyclerion Therapeutics, Inc.(0001755237)
07/31/2023 02:03
10-Q | Cyclerion Therapeutics, Inc.(0001755237)
07/28/2023 12:50
8-K | Cyclerion Therapeutics, Inc.(0001755237)
07/19/2023 13:28
8-K | Cyclerion Therapeutics, Inc.(0001755237)
07/12/2023 12:14
8-K | Cyclerion Therapeutics, Inc.(0001755237)
06/27/2023 12:54
DEFM14A | Cyclerion Therapeutics, Inc.(0001755237)
06/20/2023 12:56
8-K | Cyclerion Therapeutics, Inc.(0001755237)
06/01/2023 12:08
8-K | Cyclerion Therapeutics, Inc.(0001755237)
05/25/2023 12:06
SC 13D/A | Cyclerion Therapeutics, Inc.(0001755237)
05/23/2023 12:01
4 | Cyclerion Therapeutics, Inc.(0001755237)
05/22/2023 16:44
8-K | Cyclerion Therapeutics, Inc.(0001755237)
05/15/2023 13:17
SC 13D/A | Cyclerion Therapeutics, Inc.(0001755237)
05/12/2023 04:40
10-Q | Cyclerion Therapeutics, Inc.(0001755237)
05/12/2023 02:07
8-K | Cyclerion Therapeutics, Inc.(0001755237)
05/12/2023 02:05

Webull provides the latest Cyclerion Therapeutics Inc (CYCN) stock and general news. This information may help you make smarter investment decisions.

About CYCN

Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.